# Elpiscience (Suzhou) Biopharma

Source: https://onco.cc/companies/elpiscience-suzhou-biopharma/  
OnCo record `elpiscience-suzhou-biopharma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Elpiscience (Suzhou) Biopharma is a China-based biotechnology company running 2 late-stage cancer trials of ES014 and ES102 in desmoid tumour and non-small-cell lung cancer.

## Summary

Elpiscience (Suzhou) Biopharma, based in Suzhou, China, is a biotechnology company. Elpiscience is a biopharmaceutical company developing immunotherapies for oncology and autoimmune disease. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing ES014 and ES102 in desmoid tumour and non-small-cell lung cancer. The largest, NCT07541430 (A Study in Adults With Desmoid Tumours), plans to enrol 50 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Elpiscience (Suzhou) Biopharma, Ltd.; Elpiscience Biopharma, Ltd.
- Tags: ctgov-sponsor
- HQ: Suzhou
- Type: biotech
- Website: https://www.elpiscience.com

## Sources

- Official website: https://www.elpiscience.com
- ClinicalTrials.gov: trials led by Elpiscience (Suzhou) Biopharma: https://clinicaltrials.gov/search?lead=Elpiscience%20(Suzhou)%20Biopharma%2C%20Ltd.

## Connected records

- cancers: [Desmoid tumour](https://onco.cc/cancers/desmoid-tumour/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- trials: [A Study in Adults With Desmoid Tumors](https://onco.cc/trials/nct07541430/), [A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer](https://onco.cc/trials/nct06623136/)

---
JSON: https://onco.cc/api/v1/entities/elpiscience-suzhou-biopharma.json